UPO Book

Brief Research Description

Translational research program centering on the early clinical implementation of innovative experimental anticancer therapies to the clinic, with specific accent on anti-cancer immunotherapy.

Study of immune checkpoints inhibitors in liver cancer.

Early phase clinical trials.

Novel prognostic and predictive biomarkers in HCC.

Pathology of cancer: immune phenotyping of malignancy.

The role of innate and adaptive immunity as a prognostic marker and therapeutic monitoring of liver cancer.

Primary and metastatic liver cancer: identification and delineation of potential therapeutic targets.

HIV-associated hepatocellular cancer.

Keywords

translational research, liver cancer, immunotherapy, clinical trials,

biomarkers

PubMed